|
C2ORF34 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.476940E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.074490E-02 |
| Normal-vs-Stage2 |
7.585000E-01 |
| Normal-vs-Stage3 |
7.83300000000153E-05 |
| Normal-vs-Stage4 |
6.649300E-04 |
| Stage1-vs-Stage2 |
5.440200E-02 |
| Stage1-vs-Stage3 |
3.583800E-02 |
| Stage1-vs-Stage4 |
1.568200E-01 |
| Stage2-vs-Stage3 |
5.223000E-03 |
| Stage2-vs-Stage4 |
1.071650E-02 |
| Stage3-vs-Stage4 |
8.685000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.776500E-04 |
| Normal-vs-AfricanAmerican |
7.222300E-02 |
| Normal-vs-Asian |
8.017900E-03 |
| Caucasian-vs-AfricanAmerican |
7.120200E-01 |
| Caucasian-vs-Asian |
8.751600E-01 |
| AfricanAmerican-vs-Asian |
8.149200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.043030E-01 |
| Normal-vs-Female |
3.996600E-04 |
| Male-vs-Female |
4.708000E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.795400E-03 |
| Normal-vs-Age(41-60Yrs) |
3.242800E-03 |
| Normal-vs-Age(61-80Yrs) |
2.277700E-02 |
| Normal-vs-Age(81-100Yrs) |
2.049700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.376400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.270400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.556800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.681200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.676600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.524200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.773700E-04 |
| Classical-VS-Follicular |
1.41440000045456E-07 |
| Classical-VS-Other |
2.299000E-01 |
| Classical-VS-Normal |
3.778100E-04 |
| Tall-VS-Follicular |
3.06129566141067E-11 |
| Tall-VS-Other |
9.056100E-02 |
| Tall-VS-Normal |
1.98659999561812E-08 |
| Follicular-VS-Other |
7.869400E-01 |
| Follicular-VS-Normal |
1.899820E-01 |
| Other-VS-Normal |
5.707600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.202550E-01 |
| Normal-vs-N1 |
9.6152000000016E-05 |
| N0-vs-N1 |
2.396500E-03 |
|
|
